What is the recommended dose of colchicine (Colcrys) for acute and chronic gout management?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Colchicine Dosing for Acute and Chronic Gout Management

For acute gout flares, colchicine should be administered as a loading dose of 1.2 mg followed by 0.6 mg one hour later (total 1.8 mg), and should only be used if started within 36 hours of symptom onset. 1, 2, 3

Acute Gout Treatment

  • Colchicine is most effective when started early, ideally within 12-36 hours of flare onset 4
  • The FDA-approved regimen for acute gout flares is 1.2 mg at first sign of flare, followed by 0.6 mg one hour later (total 1.8 mg over 1 hour) 2, 3
  • After the initial doses, continue with prophylactic dosing of 0.6 mg once or twice daily (beginning 12 hours after the initial doses) until the gout attack resolves 1, 2
  • Low-dose colchicine (1.8 mg total over 1 hour) is as effective as higher doses with significantly fewer side effects 1, 5
  • The maximum recommended dose for treatment of gout flares is 1.8 mg over a one-hour period 3

Prophylaxis Dosing

  • For gout flare prophylaxis, the recommended dose is 0.6 mg once or twice daily (maximum 1.2 mg/day) 1, 4, 3
  • Prophylaxis should be initiated with or just prior to starting urate-lowering therapy 1, 2
  • Continue prophylaxis for at least 6 months, or 3 months after achieving target serum urate (if no tophi detected on physical exam), or 6 months after achieving target serum urate (if tophi are present) 1, 4

Special Considerations and Dose Adjustments

  • For patients with severe renal impairment, reduce the dose to a single dose of 0.6 mg with no repeat treatment for at least two weeks 1, 4
  • For patients on dialysis, a single dose of 0.6 mg should be administered and not repeated before two weeks 1
  • Dose reduction is required with concomitant use of moderate to high potency inhibitors of CYP3A4 and P-glycoprotein 1, 3
  • Major drug interactions requiring dose adjustment include clarithromycin, erythromycin, cyclosporine, and disulfiram 1, 6

Common Pitfalls to Avoid

  • Using colchicine beyond 36 hours after symptom onset significantly reduces its effectiveness 1, 2
  • Failing to adjust colchicine dose in patients with renal impairment or those on interacting medications can lead to toxicity 4, 6
  • Using high doses of colchicine increases the risk of adverse events (particularly gastrointestinal) without providing additional benefit 5, 7
  • Colchicine has a narrow therapeutic index with no clear distinction between nontoxic, toxic, and lethal doses 6

Alternative Options When Colchicine is Contraindicated

  • NSAIDs at full FDA-approved doses until complete resolution of the crisis 1
  • Corticosteroids, such as prednisone 0.5 mg/kg/day for 5-10 days, then stopped or tapered over 7-10 days 1
  • Intra-articular injections of corticosteroids for involvement of 1-2 large joints 1

References

Guideline

Colchicine Dosing Regimens for Gout Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Colchicine Dosage for Acute Gout and Prophylaxis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Dosing for Colchicine in Acute Gout Attacks and Febuxostat After Flare

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Colchicine for acute gout.

The Cochrane database of systematic reviews, 2014

Research

Colchicine poisoning: the dark side of an ancient drug.

Clinical toxicology (Philadelphia, Pa.), 2010

Research

Colchicine for the treatment of gout.

Expert opinion on pharmacotherapy, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.